| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,618 |
2,326 |
$241K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
718 |
611 |
$101K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
788 |
663 |
$73K |
| 80053 |
Comprehensive metabolic panel |
749 |
700 |
$61K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
661 |
617 |
$50K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,334 |
1,276 |
$44K |
| 36415 |
Collection of venous blood by venipuncture |
3,384 |
2,998 |
$36K |
| 86481 |
|
572 |
550 |
$34K |
| 80061 |
Lipid panel |
449 |
436 |
$23K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
107 |
70 |
$16K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
436 |
405 |
$16K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
273 |
257 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
222 |
216 |
$11K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
49 |
45 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
95 |
89 |
$9K |
| 86480 |
|
129 |
127 |
$9K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
151 |
144 |
$7K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
132 |
109 |
$4K |
| 84153 |
|
24 |
24 |
$2K |
| 85027 |
|
45 |
41 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
86 |
72 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
94 |
88 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
93 |
84 |
$1K |
| 82043 |
|
44 |
41 |
$1K |
| 0001A |
|
54 |
46 |
$970.85 |
| 0002A |
|
49 |
42 |
$892.49 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
24 |
24 |
$273.53 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
15 |
13 |
$232.93 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
30 |
25 |
$190.08 |
| 86140 |
|
12 |
12 |
$153.93 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
12 |
$128.43 |